Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Clovis Oncology, Inc. has filed 952 SEC EDGAR filings since 25 Jun 2009

SEC filing history

Showing 801-825 of 951 matching filings.

Per page
25
Current page
33
4

4 filing

Filing date
05 Jun 2013
Reporting date
03 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jun 2013
Reporting date
03 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jun 2013
Reporting date
03 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jun 2013
Reporting date
03 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jun 2013
Reporting date
03 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jun 2013
Reporting date
03 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
03 Jun 2013
Reporting date
03 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
03 Jun 2013
Reporting date
03 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
07 May 2013
Reporting date
07 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-188063

EFFECT filing

Filing date
02 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35347

DEFA14A

Filing date
29 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35347

DEFINITIVE PROXY STATEMENT

Filing date
29 Apr 2013
Reporting date
13 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-188063

FORM S-3

Filing date
22 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Mar 2013
Reporting date
04 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Mar 2013
Reporting date
04 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2013
Reporting date
01 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2013
Reporting date
01 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2013
Reporting date
01 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2013
Reporting date
01 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2013
Reporting date
01 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8K

Filing date
28 Feb 2013
Reporting date
28 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

FORM 8-K

Filing date
19 Feb 2013
Reporting date
14 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
15 Feb 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .